DanielPPetroMD

PubMed

• 13 citations
  Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck Cancer.
  Robert L Ferris, Jessica Moskovitz, Sheryl Kunning, Ayana T Ruffin, Carly Reeder, James Ohr, William E Gooding, Seungwon Kim, Brian J Karlovits, Dario A A Vignali, Uma...> ;Clinical Cancer Research. 2022 Apr 1
• 46 citations
  SWOG S1400C (NCT02154490)—A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration–Positive Patients with Stage IV Squamous Cell Lung Cancer (...
  Martin J. Edelman, Mary W. Redman, Kathy S. Albain, Eric C. McGary, Noman M. Rafique, Daniel P. Petro, Saiama N. Waqar, Katherine Minichiello, Jieling Miao, Vassiliki ...> ;Journal of Thoracic Oncology. 2019 Oct 1
• 28 citations
  Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies
  Leonard Joseph Appleman, Jan H. Beumer, Yixing Jiang, Yan Lin, Fei Ding, Shannon Puhalla, Leigh Swartz, Taofeek K. Owonikoko, R. Donald Harvey, Ronald G. Stoller, Dani...> ;Cancer Chemotherapy and Pharmacology. 2019 Dec 1
• 54 citations
  Initial Results of a Multicenter Phase 2 Trial of Stereotactic Ablative Radiation Therapy for Oligometastatic Cancer
  Philip A. Sutera, David A. Clump, Ronny Kalash, David J. D'Ambrosio, Alina Mihai, Hong Wang, Daniel P. Petro, Steven A. Burton, Dwight E. Heron> ;International Journal of Radiation Oncology, Biology, Physics. 2019 Jan 1
• 11 citations
  Phase I study of veliparib in combination with gemcitabine.
  Ronald G. Stoller, John C. Schmitz, Fei Ding, Shannon Puhalla, Chandra P. Belani, Leonard Joseph Appleman, Yan Lin, Yixing Jiang, Salah Almokadem, Daniel P. Petro, Jul...> ;Cancer Chemotherapy and Pharmacology. 2017 Aug 2
• 31 citations
  Phase 1/2 study of rilotumumab (AMG 102), a hepatocyte growth factor inhibitor, and erlotinib in patients with advanced non–small cell lung cancer
  Ahmad A. Tarhini, Imran Rafique, Theofanis Floros, Phu Tran, William E. Gooding, Liza C. Villaruz, Timothy F. Burns, David M. Friedland, Daniel P. Petro, Mariya Farooq...> ;Cancer. 2017 Aug 1
• 18 citations
  A multicenter phase II study of cetuximab in combination with chest radiotherapy and consolidation chemotherapy in patients with stage III non-small cell lung cancer
  Suresh S. Ramalingam, Athanasios Kotsakis, Ahmad A. Tarhini, Dwight E. Heron, Roy E. Smith, David M. Friedland, Daniel P. Petro, Luis E. Raez, Julie R. Brahmer, Joel S...> ;Lung Cancer. 2013 Sep 1
• 42 citations
  A Phase I Study of Concurrent Chemotherapy (Paclitaxel and Carboplatin) and Thoracic Radiotherapy with Swallowed Manganese Superoxide Dismutase Plasmid Liposome Protec...
  Ahmad A. Tarhini, Chandra P. Belani, James D. Luketich, Athanassios Argiris, Suresh S. Ramalingam, William E. Gooding, Arjun Pennathur, Daniel P. Petro, Kevin Kane, De...> ;Human Gene Therapy. 2011 Mar 1
• 103 citations
  Phase II study of everolimus (RAD001) in previously treated small cell lung cancer.
  Ahmad A. Tarhini, Athanassios Kotsakis, William E. Gooding, Yongli Shuai, Daniel P. Petro, David M. Friedland, Chandra P. Belani, Sanja Dacic, Athanassios Argiris> ;Clinical Cancer Research. 2010 Dec 1
• Join now to see all